Vertigo Drugs Market by Type, Distribution Channel and Geography - Forecast and Analysis 2023-2027

Vertigo Drugs Market Forecast 2023-2027

The global vertigo drugs market size is estimated to grow by USD 551.42 million at a CAGR of 5.58% between 2022 and 2027. A significant driver propelling the global market is the escalating demand for the drugs observed in developing nations. These include rapidly growing economies like India, China, Brazil, South Africa, Indonesia, Mexico, among others. These regions are experiencing a surge in healthcare expenditures alongside rapid economic growth, fostering a heightened demand for advanced medical treatments and pharmaceuticals. Moreover, the ongoing expansion of healthcare infrastructure across these emerging economies is playing a pivotal role in driving the demand for the treatments. Investments in hospitals, clinics, and pharmacies are enhancing healthcare accessibility and contributing to the availability of a diverse range of medications. Consequently, the burgeoning demand in emerging markets is anticipated to fuel market growth throughout the forecast period.

What will be the Size of the Vertigo Drugs Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation

By Type Analysis

The market share growth by the peripheral vertigo segment will be significant during the forecast period. An issue with the portion of the inner ear that controls balance is the cause ofthis segment. These areas are called the vestibular labyrinth or semicircular canals. The vestibular nerve may potentially be a factor in the issue. This nerve links the inner ear to the brain stem. Approximately 80% of vertigo is peripheral.

Get a glance at the market contribution of various segments View a PDF Sample

The peripheral vertigo segment was valued at USD 1.07 billion in 2017. This condition may be caused by injury, certain medicines, such as aminoglycoside antibiotics, cisplatin, irritation and swelling of the inner ear, meniere disease, and others. Patients typically develop rapid, severe nausea, vomiting, and gait instability. Antihistamines, benzodiazepines, corticosteroids, antiemetics, and anticholinergics may be used in the treatment of this segment. Furthermore, various market players, such as Sensorion and Viatris provide drugs for this segment, which will boost the segment during the forecast period.

Distributuon Channel Analysis 

Offline segment

The offline segment held the largest share of the global market in 2022. The majority of customers prefer to buy through offline distribution channels because they offer product assurance, authenticity, and verification. Besides, offline retailers give customers convenience, personalization, and personal support. Moreover, companies and market players significantly invest in brick-and-mortar organized pharmaceutical retail stores to raise their regional and global shares in the market. companies are investing in brick-and-mortar stores to sell due to the increased footfall in offline stores. Due to the rise in the retail sector, it is expected to fuel offline segment growth during the forecast period.

Regional Analysis

For more insights about various regions' market share, View PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have explained the regional trends and drivers that will shape the market during the forecast period. North America involves nations like the US, Canada, and Mexico, and it addresses the development, manufacturing, and consumption, which is driving the development of the regional market.

Moreover, several prominent pharmaceutical companies that develop and manufacture medications for  treatment are based in the region. Amneal Pharmaceuticals, Epic Pharma, and Viatris are a few of the market's companies. With large-scale investments in research and development (R&D), these companies introduce innovative drugs with enhanced efficacy and safety profiles. The region's availability of a wide range of vertigo medications is facilitated by the region's well-established pharmaceutical infrastructure and expertise, boosting the growth of the market during the forecast period.

Buy Now Full Report and Discover More

Key Vertigo Drugs Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies,

 Altamira Therapeutics Ltd.: The company offers vertigo drugs such as ALTA-5206.

• AdvaCare Pharma
• Amneal Pharmaceuticals Inc.
• Endo International Plc
•  Epic Pharma LLC
•  F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
•  Indicus Pharma
•  Intas Pharmaceuticals Ltd.
• Jubilant Pharmova Ltd.
• Lupin Ltd.
• Novartis AG
•  Otonomy Inc.
• Pfizer Inc.
• Sensorion
• Sound Pharmaceuticals
• Sun Pharmaceutical Industries Ltd.
• Suven Life Sciences Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

The growing prevalence of vertigo and associated health concerns is a prominent driver for the Market. Lifestyle factors such as obesity, respiratory problems, diabetes, and high cholesterol levels contribute to the incidence of vertigo among overweight and obese individuals. As the global population continues to grapple with chronic and acute diseases, the demand for vertigo medications, including those addressing atherosclerosis and cardiovascular issues, rises. Additionally, advancements in cardiac surgeries, heart transplantations, and other surgical procedures necessitate effective vertigo management pharmaceuticals to mitigate post-operative symptoms like chest pain and dizziness. Moreover, the adoption of statins for managing cholesterol levels underscores the need for vertigo drugs, further propelling market growth.

In parallel, a notable trend in the Market is the integration of innovative technologies to enhance patient care and treatment outcomes. The adoption of customer relationship management (CRM) systems enables pharmaceutical companies to streamline interactions with healthcare providers and optimize revenue generation. Furthermore, the increasing demand for web and mobile self-services allows patients to access information about vertigo medications conveniently, fostering real-time communication and instant assistance. Additionally, the integration of social media platforms facilitates engagement with end-users, providing valuable insights into user behavior and enhancing the overall customer experience. As the e-commerce sector continues to expand, the deployment of interactive chatbots and customer messaging software enables personalized interactions and supports the management of vertigo-related inquiries, catering to the diverse needs of first-time website visitors, existing users, and returning customers.

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key trends, and challenges. 

Significant Market Trends

The burgeoning trend of integrating digital health solutions into the treatment is significantly propelling the growth of the global market. This integration represents a pivotal shift in patient care strategies, leveraging innovative digital platforms to enhance vertigo management. Digital health solutions, including telehealth platforms, are revolutionizing the way vertigo symptoms are tracked, monitored, and addressed. Through telehealth platforms, patients can access remote consultations and virtual visits with healthcare professionals, facilitating real-time guidance and monitoring of their condition.

The integration of digital health solutions offers a multitude of benefits for the treatment. By enabling real-time data collection and remote monitoring, these solutions facilitate timely interventions and adjustments to treatment regimens, ultimately leading to improved patient outcomes. Moreover, digital health solutions enhance patient engagement and empowerment, fostering a more proactive approach to vertigo management. As a result, the integration of digital health solutions is expected to drive significant advancements in vertigo treatment and contribute to the growth of the market in the forecast period.

Major Market Challenges

The presence of generic drugs in the past few years has harmed the growth of the global market. Generic drugs are defined as inexpensive drugs that contain the same active ingredient (API) as branded drugs. These drugs are launched shortly after the brand loses its patent exclusivity. Following the loss of patent exclusivity, the generic competition for a product increases, leading to a decline in the sale of branded drugs as the generic competitor enters the market with the same product at lower prices.

Moreover, generic drugs also make the threat of new entrants in the market, which will damage the market position of the existing companies and market players. Once these generics are launched in developed countries, they reach developing countries within a short period. Such instances will impede the market growth during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

• Type Outlook 
  • Peripheral vertigo
  • Central vertigo

• Distribution Channel Outlook
  • Offline
  • Online

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • Rest of the World (ROW)
    • Brazil 
    • Australia 
    • Argentina

Market Analyst Overview

The market is witnessing significant growth owing to the increasing prevalence of vertigo, often caused by viral or bacterial infections, inner ear inflammation, or disorders in the brain. With technological advancements and ongoing innovation, new treatments are emerging to address symptoms like spinning dizziness and difficulty in balancing. Pharmaceutical companies, both public and private, are investing in research and development, leading to new product launches and expansions. Additionally, mergers, acquisitions, and joint ventures are shaping the market landscape. As the geriatric population grows and healthcare expenditure rises, there is a heightened demand for vertigo treatments. Vertigo drugs like dimenhydrinate and meclizine are commonly prescribed, available in various forms from hospital pharmacies to online providers, catering to the needs of patients globally.

The vertigo treatment market is a dynamic sector influenced by various factors, including advancements in medical research, changes in healthcare policies, and the occurrence of health conditions like vertigo and dizziness. As public and private companies invest in research and development, the market for vertigo treatments evolves to meet the needs of patients experiencing these debilitating symptoms.

In recent times, the pandemic has posed unique challenges, with social distancing measures affecting patient visits to healthcare facilities. However, studies published in journals such as the Ear Nose and Throat Journal and the Journal of Neurology provide valuable insights into the incidence and prevalence of peripheral etiologies of vertigo, helping doctors better understand and manage these conditions. The impact of vertigo is particularly significant among specific demographics, including women, elderly people, and nursing home patients. Research published in outlets like the BioMed Central (BMC) Geriatric Journal sheds light on the prevalence of vertigo in these populations and underscores the importance of tailored treatment approaches.

Key contributors to vertigo include conditions such as Meniere's Disease, benign paroxysmal positional vertigo (BPPV), vestibular neuritis, and labyrinthitis, each requiring targeted interventions. Clinical trials, including phase 3 trials, play a crucial role in evaluating the efficacy and safety of potential treatments for these conditions. Treatment options range from medications such as water pills and antidepressants, available both over-the-counter and through drug stores and retail pharmacies, to physical therapy and surgical interventions in severe cases. Collaboration between healthcare professionals, researchers, and pharmaceutical companies is essential in advancing treatment options and improving patient outcomes.As research continues to uncover the underlying causes of vertigo and dizziness, including disorders in the brain or inner ear, efforts are made to enhance diagnostic accuracy and develop personalized treatment plans. Through initiatives led by organizations like the National Center for Biotechnology Information (NCBI) and the World Health Organization (WHO), the vertigo treatment market strives to address the diverse needs of patients across the globe, ensuring access to quality care for all.

Vertigo Drugs Market Scope
Report Coverage	Details
Page number	149
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 5.58%
Market growth 2023-2027	USD 551.42 million
Market structure	Fragmented
YoY growth 2022-2023(%)	4.69
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks
Key companies profiled	AdvaCare Pharma, Altamira Therapeutics Ltd., Amneal Pharmaceuticals Inc., Endo International Plc, Epic Pharma LLC, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Indicus Pharma, Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Lupin Ltd., Novartis AG, Otonomy Inc., Pfizer Inc., Sensorion, Sound Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Suven Life Sciences Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.
Market dynamics	Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch